Clinical Trial Update: Study Comparing Racivir and Lamivudine in Treatment-Experienced HIV Subjects [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial comparing Racivir and Lamivudine in treatment-experienced HIV subjects has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Lamivudine (lamivudine)
• Racivir

Snippet

Sponsor: Pharmasset | Conditions: HIV Infections | Phase 2 | Status: COMPLETED